돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 9591생성일: 2026년 10월 23일

2-Chlorobenzimidazole → 4-[4'-(1H-Benzimidazol-2-ylamino)-1,1-biphenyl-4-yl]-2,2-dimethyl-4-oxobutanoic acid

https://huagongshe.com/ko/reaction/9591

반응식

참여 물질

역할이름HCID투입량
반응물2-ChlorobenzimidazoleHCID 78572—
반응물4-[4'-(1,3-Benzothiazol-2-ylamino)-1,1'-biphenyl-4-yl]-2,2-dimethyl-4-oxobutanoic acidHCID 11475930—
반응물Methyl 4-(4'-amino-1,1'-biphenyl-4-yl)-2,2-dimethyl-4-oxobutanoateHCID 21985743—
생성물4-[4'-(1H-Benzimidazol-2-ylamino)-1,1-biphenyl-4-yl]-2,2-dimethyl-4-oxobutanoic acidHCID 980184148%

반응 단계

This compound was prepared from methyl 4-(4′-amino-1,1′-biphenyl-4-yl)-2,2-dimethyl-4-oxobutanoate (64 mg, 0.21 mmol) and 2-chloro-1H-benzimidazole (37.6 mg, 0.25 mmol) in a similar manner to the method described for 4-[4′-(1,3-benzothiazol-2-ylamino)-1,1′-biphenyl-4-yl]-2,2-dimethyl-4-oxobutanoic acid, providing 40.7 mg (48%) of the desired product. 1H NMR (400 MHz, DMSO-d6) δ 12.00 (br s, 1 H), 11.05 (br s, 1 H), 8.05 (d, 2 H), 7.85 (m, 4 H), 7.65 (d, 2 H), 7.40 (m, 2 H), 7.10 (m, 2 H), 3.35 (s, 2 H), 1.25 (s, 6 H). LC-MS m/z 414.3 (MH+), ret. time 2.27 min.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07091228B2
출처 데이터셋uspto-grants-2006_08
ORD IDord-c562ef6bea554331af07322689ed1205
출처 메모uspto-grants-2006_08